Developmental nicotine exposure and masculinization of the rat preoptic area.

Journal Article (Journal Article)

Nicotine is a neuroteratogenic component of tobacco smoke, e-cigarettes, and other products and can exert sex-specific effects in the developing brain, likely mediated through sex hormones. Estradiol modulates expression of nicotinic acetylcholine receptors in rats, and plays critical roles in neurodevelopmental processes, including sexual differentiation of the brain. Here, we examined the effects of developmental nicotine exposure on the sexual differentiation of the preoptic area (POA), a brain region that normally displays robust structural sexual dimorphisms and controls adult mating behavior in rodents. Using a rat model of gestational exposure, developing pups were exposed to nicotine (2 mg/kg/day) via maternal osmotic minipump (subcutaneously, sc) throughout the critical window for brain sexual differentiation. At postnatal day (PND) 4, a subset of offspring was analyzed for epigenetic effects in the POA. At PND40, all offspring were gonadectomized, implanted with a testosterone-releasing capsule (sc), and assessed for male sexual behavior at PND60. Following sexual behavior assessment, the area of the sexually dimorphic nucleus of the POA (SDN-POA) was measured using immunofluorescent staining techniques. In adults, normal sex differences in male sexual behavior and in the SDN-POA area were eliminated in nicotine-treated animals. Using novel analytical approaches to evaluate overall masculinization of the adult POA, we identified significant masculinization of the nicotine-treated female POA. In neonates (PND4), nicotine exposure induced trending alterations in methylation-dependent masculinizing gene expression and DNA methylation levels at sexually-dimorphic differentially methylated regions, suggesting that developmental nicotine exposure is capable of triggering masculinization of the rat POA via epigenetic mechanisms.

Full Text

Duke Authors

Cited Authors

  • Joglekar, R; Cauley, M; Lipsich, T; Corcoran, DL; Patisaul, HB; Levin, ED; Meyer, JN; McCarthy, MM; Murphy, SK

Published Date

  • March 2022

Published In

Volume / Issue

  • 89 /

Start / End Page

  • 41 - 54

PubMed ID

  • 35026373

Pubmed Central ID

  • PMC8917982

Electronic International Standard Serial Number (EISSN)

  • 1872-9711

Digital Object Identifier (DOI)

  • 10.1016/j.neuro.2022.01.005

Language

  • eng

Conference Location

  • Netherlands